Myelodysplastic Syndrome VA Disability Rating is rated by the U.S. Department of Veterans Affairs under DC 7716 of 38 C.F.R. § 4.117 across 4 severity tiers (100% -- Severe systemic disease / 60% -- Moderate to severe disease / 30% -- Moderate disease / 10% -- Mild disease). Service connection requires (1) a current diagnosis, (2) an in-service event, injury, or exposure, and (3) a medical nexus opinion linking the two under 38 C.F.R. § 3.303.
Myelodysplastic syndromes are pre-leukemic blood disorders rated under DC 7716. Requiring transfusions rates high. May be presumptive for radiation or chemical exposure.
Myelodysplastic Syndrome (DC 7716) is evaluated under 38 C.F.R. § 4.117 using the hematologic rating framework. Because it is rated by analogy to the general schedule, the 4 levels below describe the body-system criteria the VA applies — the percentage assigned to Myelodysplastic Syndrome depends on the specific findings (range of motion, frequency, severity, or functional loss) documented at the C&P exam and in the medical record.
Rating criteria reference 38 C.F.R. Part 4 (Schedule for Rating Disabilities). This entry has not yet undergone editorial review against the live regulation text — consult the authoritative source directly before relying on the criteria shown.